Vanguard Group
YTEN

Vanguard Group’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-40,451
Closed -$15.4K 4492
2024
Q1
$15.4K Hold
40,451
﹤0.01% 4408
2023
Q4
$9.68K Hold
40,451
﹤0.01% 4479
2023
Q3
$13.2K Sell
40,451
-66,427
-62% -$21.7K ﹤0.01% 4515
2023
Q2
$237K Hold
106,878
﹤0.01% 4284
2023
Q1
$295K Buy
106,878
+3,415
+3% +$9.43K ﹤0.01% 4253
2022
Q4
$173K Buy
103,463
+92
+0.1% +$154 ﹤0.01% 4332
2022
Q3
$309K Sell
103,371
-10,979
-10% -$32.8K ﹤0.01% 4338
2022
Q2
$257K Sell
114,350
-2,641
-2% -$5.94K ﹤0.01% 4433
2022
Q1
$620K Hold
116,991
﹤0.01% 4344
2021
Q4
$576K Hold
116,991
﹤0.01% 4404
2021
Q3
$701K Buy
116,991
+1,564
+1% +$9.37K ﹤0.01% 4322
2021
Q2
$985K Buy
115,427
+37,871
+49% +$323K ﹤0.01% 4149
2021
Q1
$972K Buy
+77,556
New +$972K ﹤0.01% 4016
2020
Q1
Sell
-103,390
Closed -$18K 4102
2019
Q4
$18K Hold
103,390
﹤0.01% 4095
2019
Q3
$52K Hold
103,390
﹤0.01% 4083
2019
Q2
$98K Hold
103,390
﹤0.01% 4051
2019
Q1
$118K Hold
103,390
﹤0.01% 3999
2018
Q4
$86K Sell
103,390
-48
-0% -$40 ﹤0.01% 4014
2018
Q3
$147K Hold
103,438
﹤0.01% 4042
2018
Q2
$146K Buy
103,438
+37,100
+56% +$52.4K ﹤0.01% 4019
2018
Q1
$129K Buy
+66,338
New +$129K ﹤0.01% 4011
2017
Q2
Sell
-12,480
Closed -$4K 4086
2017
Q1
$4K Hold
12,480
﹤0.01% 4067
2016
Q4
$4K Sell
12,480
-64,070
-84% -$20.5K ﹤0.01% 4076
2016
Q3
$35K Sell
76,550
-29,404
-28% -$13.4K ﹤0.01% 4053
2016
Q2
$88K Hold
105,954
﹤0.01% 4036
2016
Q1
$201K Hold
105,954
﹤0.01% 3961
2015
Q4
$163K Buy
105,954
+8,511
+9% +$13.1K ﹤0.01% 4032
2015
Q3
$134K Hold
97,443
﹤0.01% 4070
2015
Q2
$365K Sell
97,443
-465,235
-83% -$1.74M ﹤0.01% 3945
2015
Q1
$349K Buy
562,678
+24,047
+4% +$14.9K ﹤0.01% 3909
2014
Q4
$215K Hold
538,631
﹤0.01% 3893
2014
Q3
$490K Sell
538,631
-9,282
-2% -$8.44K ﹤0.01% 3716
2014
Q2
$477K Hold
547,913
﹤0.01% 3694
2014
Q1
$713K Buy
547,913
+69,652
+15% +$90.6K ﹤0.01% 3557
2013
Q4
$603K Buy
478,261
+200
+0% +$252 ﹤0.01% 3544
2013
Q3
$603K Hold
478,061
﹤0.01% 3505
2013
Q2
$679K Buy
+478,061
New +$679K ﹤0.01% 3405